These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1376196)

  • 1. Benign prostatic hyperplasia. The scope of the problem.
    Grayhack JT
    Cancer; 1992 Jul; 70(1 Suppl):275-9. PubMed ID: 1376196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of benign prostatic hyperplasia.
    Isaacs JT
    Eur Urol; 1994; 25 Suppl 1():6-9. PubMed ID: 7507055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of benign prostatic hyperplasia on general well-being of men.
    Tsang KK; Garraway WM
    Prostate; 1993; 23(1):1-7. PubMed ID: 7687780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of conditions potentially associated with lower urinary tract symptoms in men.
    Gades NM; Jacobson DJ; Girman CJ; Roberts RO; Lieber MM; Jacobsen SJ
    BJU Int; 2005 Mar; 95(4):549-53. PubMed ID: 15705078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiopathogenesis of benign prostatic hypertrophy].
    Montanari E; Guarneri A; Dell'Orto P; Gelosa M
    Arch Ital Urol Androl; 1995 Feb; 67(1):7-12. PubMed ID: 7538393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostate hyperplasia and stem cells: a new therapeutic opportunity.
    Notara M; Ahmed A
    Cell Biol Toxicol; 2012 Dec; 28(6):435-42. PubMed ID: 23065175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology and disease process of benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Prostate Suppl; 1989; 2():33-50. PubMed ID: 2482772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.